Loteprednol Etabonate Ophthalmic Gel, 0.38% (RLD Lotemax SM) had an estimated annual sale of USD 36 million in the U.S.

Lupin's Pithampur manufacturing unit produces both APIs (Active Pharmaceutical Ingredients) and finished products ...

Mumbai: Global pharma major Lupin Limited has announced that it has received the Establishment Inspection Report (EIR) from ...

Lupin receives US FDA tentative approval for loteprednol etabonate ophthalmic gel: Our Bureau, Mumbai Thursday, January 9, 2025, 17:20 Hrs [IST] Global pharma major Lupin Limited ...

Catalyst Pharmaceuticals (CPRX) announced that the company and its licensor SERB S.A. have entered into a Settlement Agreement with Teva ...

Lupin’s Pithampur Unit-1 facility gets EIR from US FDA with VAI classification: Our Bureau, Mumbai Thursday, January 9, 2025, 12:30 Hrs [IST] Global pharma major Lupin Limited ( ...

The price crash comes just after a significant legal decision regarding Bitcoin seized from the Silk Road, a dark web ...

Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for ...

Catalyst Pharmaceuticals, Inc. ("Catalyst" or "Company") (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing ...

Given that more than 40% of Indian adults are struggling with obesity and diabetes, affordable weight-loss drugs are expected to significantly disrupt the pharmaceutical landscape in the country this ...

Lupin receives USFDA approval for its generic version of Ivacaftor oral granules, a treatment for cystic fibrosis. The ...